| 摘要 |
The drug for improving the reaction of the ovary and the production of ova and embryos in domestic mammals in connection with biotechnological embryo transfer is characterized in that it consists of inhibin-neutralizing antibodies or of said antibodies in combination with hormones which promote superovulations, which are directed against animal and human, natural or recombinant inhibin or its subunits, fragments and derivatives, and can neutralize the biological activity of the inhibin produced in the gonads and thereby bring about, within one reproductive cycle, multiple follicle growth and multiple follicle ripening up to multiple ovulation by passive immunization, and by its alternative embodiment and by a process for producing it. |
